ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA)

CUSIP: 488445206

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock
Shares outstanding
56,066,823
Total 13F shares
5,912,306
Share change
-715,245
Total reported value
$27,146,724
Put/Call ratio
76%
Price per share
$4.59
Number of holders
66
Value change
-$3,423,716
Number of buys
30
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 488445206?
CUSIP 488445206 identifies ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Samuel J. Braun
3/4/5
10%+ Owner
class O/S missing
3,153,000
$15,636,043 13 May 2021
VANGUARD GROUP INC
13F
Company
2.5%
1,380,638
$8,615,000 30 Sep 2022
13F
BlackRock Finance, Inc.
13F
Company
1.5%
847,611
$5,290,000 30 Sep 2022
13F
Atle Fund Management AB
13F
Company
1.3%
750,000
$4,680,000 30 Sep 2022
13F
Laurion Capital Management LP
13F
Company
1%
571,200
$3,564,000 30 Sep 2022
13F
Janney Montgomery Scott LLC
13F
Company
0.86%
479,380
$2,991,000 30 Sep 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.54%
304,652
$1,901,000 30 Sep 2022
13F
Retirement Planning Co of New England, Inc.
13F
Company
0.54%
302,820
$1,889,000 30 Sep 2022
13F
SABBY MANAGEMENT, LLC
13F
Company
0.44%
248,592
$1,551,000 30 Sep 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.29%
165,303
$1,031,000 30 Sep 2022
13F
Mystic Asset Management, Inc.
13F
Company
0.29%
164,883
$1,028,000 30 Sep 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.26%
144,745
$903,000 30 Sep 2022
13F
Travis C. Mickle
3/4/5
President & CEO, Director
class O/S missing
171,774
$851,845 25 May 2022
Ergoteles LLC
13F
Company
0.22%
122,000
$761,000 30 Sep 2022
13F
Bank of New York Mellon Corp
13F
Company
0.21%
118,165
$738,000 30 Sep 2022
13F
Kovack Advisors, Inc.
13F
Company
0.19%
109,054
$680,000 30 Sep 2022
13F
STATE STREET CORP
13F
Company
0.18%
102,640
$640,000 30 Sep 2022
13F
Arete Wealth Advisors, LLC
13F
Company
0.14%
78,565
$490,000 30 Sep 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.13%
71,900
$449,000 30 Sep 2022
13F
Stratos Wealth Partners, LTD.
13F
Company
0.13%
70,200
$438,000 30 Sep 2022
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.12%
68,943
$430,000 30 Sep 2022
13F
NORTHERN TRUST CORP
13F
Company
0.09%
52,791
$329,000 30 Sep 2022
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.09%
52,722
$329,000 30 Sep 2022
13F
SIMPLEX TRADING, LLC
13F
Company
0.09%
49,593
$309,000 30 Sep 2022
13F
Strategic Asset Management, LLC
13F
Company
0.07%
41,743
$260,000 30 Sep 2022
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.05%
29,800
$185,000 30 Sep 2022
13F
Man Group plc
13F
Company
0.05%
29,278
$183,000 30 Sep 2022
13F
OCCUDO QUANTITATIVE STRATEGIES LP
13F
Company
0.05%
27,312
$170,000 30 Sep 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.05%
26,413
$165,000 30 Sep 2022
13F
Raymond James Financial Services Advisors, Inc.
13F
Company
0.04%
22,530
$141,000 30 Sep 2022
13F
Qube Research & Technologies Ltd
13F
Company
0.04%
21,833
$136,000 30 Sep 2022
13F
IFP Advisors, Inc
13F
Company
0.02%
9,250
$134,000 30 Sep 2022
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.04%
20,220
$126,000 30 Sep 2022
13F
Cubist Systematic Strategies, LLC
13F
Company
0.04%
19,771
$123,000 30 Sep 2022
13F
MORGAN STANLEY
13F
Company
0.03%
17,583
$109,000 30 Sep 2022
13F
World Investment Advisors
13F
Company
0.03%
16,350
$102,000 30 Sep 2022
13F
Atom Investors LP
13F
Company
0.03%
14,080
$88,000 30 Sep 2022
13F
City State Bank
13F
Company
0.02%
13,724
$86,000 30 Sep 2022
13F
Kingsview Wealth Management, LLC
13F
Company
0.02%
12,120
$76,000 30 Sep 2022
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.02%
11,610
$72,000 30 Sep 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.02%
11,139
$70,000 30 Sep 2022
13F
Private Advisor Group, LLC
13F
Company
0.02%
10,790
$67,000 30 Sep 2022
13F
LPL Financial LLC
13F
Company
0.02%
10,700
$67,000 30 Sep 2022
13F
LMR Partners LLP
13F
Company
0.02%
10,572
$66,000 30 Sep 2022
13F
Balefire, LLC
13F
Company
0.02%
10,217
$64,000 30 Sep 2022
13F
Caption Management, LLC
13F
Company
0.02%
10,000
$62,000 30 Sep 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
6,041
$38,000 30 Sep 2022
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
5,150
$32,000 30 Sep 2022
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
4,230
$26,000 30 Sep 2022
13F
CITIGROUP INC
13F
Company
0.01%
4,029
$25,000 30 Sep 2022
13F

Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) as of Q4 2022

As of 31 Dec 2022, ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) was held by 66 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,912,306 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Laurion Capital Management LP, Janney Montgomery Scott LLC, HealthInvest Partners AB, GEODE CAPITAL MANAGEMENT, LLC, Retirement Planning Co of New England, Inc., Mystic Asset Management, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, and Bank of New York Mellon Corp. This page lists 67 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
63
Q4 2022 holders
66
Holder diff
3
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 Value $ Q4 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.